{"id":"https://openalex.org/W40717230","doi":null,"title":"Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.","display_name":"Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.","publication_year":1986,"publication_date":"1986-04-01","ids":{"openalex":"https://openalex.org/W40717230","mag":"40717230","pmid":"https://pubmed.ncbi.nlm.nih.gov/2939012"},"language":"en","primary_location":{"id":"pmid:2939012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2939012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Herz","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108597123","display_name":"Hiltrud S. Mueller","orcid":"https://orcid.org/0000-0002-7718-4931","observed_orcids":["https://orcid.org/0000-0002-7718-4931"]},"institutions":[{"id":"https://openalex.org/I19772626","display_name":"Yeshiva University","ror":"https://ror.org/045x93337","country_code":"US","type":"education","lineage":["https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H S Mueller","raw_affiliation_strings":["Yeshiva University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yeshiva University","institution_ids":["https://openalex.org/I19772626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111668546","display_name":"Parinam S. Rao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19772626","display_name":"Yeshiva University","ror":"https://ror.org/045x93337","country_code":"US","type":"education","lineage":["https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P S Rao","raw_affiliation_strings":["Yeshiva University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yeshiva University","institution_ids":["https://openalex.org/I19772626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061744157","display_name":"M A Greenberg","orcid":"https://orcid.org/0000-0001-6623-9899","observed_orcids":["https://orcid.org/0000-0001-6623-9899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Greenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035834236","display_name":"Peter M. Buttrick","orcid":"https://orcid.org/0000-0002-5692-2691","observed_orcids":["https://orcid.org/0000-0002-5692-2691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P M Buttrick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077316228","display_name":"Ira I. Sussman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I I Sussman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113662019","display_name":"Howard A. Levite","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H A Levite","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036212746","display_name":"Richard Grose","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R M Grose","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017087583","display_name":"V Perez-Davila","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Perez-Davila","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111534435","display_name":"Janet E. Strain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J E Strain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110886482","display_name":"Theodore H. Spaet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T H Spaet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.525,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.63074646,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"2","first_page":"116","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.14659999310970306,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-hyperreactivity","display_name":"platelet hyperreactivity","score":0.871999979019165},{"id":"https://openalex.org/keywords/acute-myocardial-infarction","display_name":"acute myocardial infarction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prostacyclin","display_name":"prostacyclin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/thromboxane-b2","display_name":"thromboxane B2","score":0.8870000243186951},{"id":"https://openalex.org/keywords/beta-thromboglobulin","display_name":"beta-thromboglobulin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/6-keto-prostaglandin-f1-alpha","display_name":"6-keto-prostaglandin F1alpha","score":0.8930000066757202},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.5490000247955322},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/coronary-sinus","display_name":"coronary sinus","score":0.42399999499320984},{"id":"https://openalex.org/keywords/ischemic-myocardium","display_name":"ischemic myocardium","score":0.7039999961853027},{"id":"https://openalex.org/keywords/adenosine-diphosphate","display_name":"adenosine diphosphate","score":0.8140000104904175},{"id":"https://openalex.org/keywords/platelet-function","display_name":"platelet function","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8895539045333862},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.8276652693748474},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.7947149872779846},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6449524164199829},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6202472448348999},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5832246541976929},{"id":"https://openalex.org/C2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","level":3,"score":0.5662499666213989},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.521798849105835},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.5088682174682617},{"id":"https://openalex.org/C2778259205","wikidata":"https://www.wikidata.org/wiki/Q629460","display_name":"Coronary sinus","level":2,"score":0.4413371980190277},{"id":"https://openalex.org/C2781080829","wikidata":"https://www.wikidata.org/wiki/Q3009646","display_name":"Thromboxane B2","level":3,"score":0.4146120548248291},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34197449684143066}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001620","descriptor_name":"beta-Thromboglobulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004837","descriptor_name":"Epinephrine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013928","descriptor_name":"Thromboxane A2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013929","descriptor_name":"Thromboxane B2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015121","descriptor_name":"6-Ketoprostaglandin F1 alpha","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2939012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2939012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Herz","raw_type":"Journal Article"},{"id":"mag:40717230","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2939012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1974456921","https://openalex.org/W2051468537","https://openalex.org/W1994153882","https://openalex.org/W1970375739","https://openalex.org/W2172229931","https://openalex.org/W2883771993","https://openalex.org/W2160073976","https://openalex.org/W3152259064","https://openalex.org/W2167994940","https://openalex.org/W2400818512"],"abstract_inverted_index":{"There":[0],"is":[1,28,168,223,239,258],"increasing":[2],"evidence":[3],"that":[4,237,302],"platelets":[5],"play":[6],"an":[7,19,120,266],"important":[8],"role":[9],"in":[10,45,147,190,201,204,245,284,306,338],"the":[11,46,51,55,65,162,178,213,242,263,285,299,303,307,339],"pathogenesis":[12],"of":[13,21,57,67,79,101,115,139,143,150,166,177,207,247,256,269,298,321,335,341],"acute":[14,308,342],"ischemic":[15],"heart":[16],"disease.":[17],"Therefore,":[18],"understanding":[20],"factors":[22],"which":[23],"impact":[24],"on":[25],"platelet":[26,43,59,124,151,208,221,270,281,313,336],"performance":[27],"important.":[29],"The":[30,132,220,253,295,326],"present":[31],"study":[32],"was":[33],"undertaken":[34],"1.":[35],"to":[36,63,128,192,198,216,293],"characterize":[37],"during":[38,183,227,272],"evolving":[39,83,184,273],"myocardial":[40,53,343],"infarction":[41],"(MI)":[42],"activity":[44],"peripheral":[47,286],"circulation":[48],"and":[49,61,75,93,97,126,142,156,195,203,212,230,287,290,316],"across":[50,241],"ischemic/infarcting":[52,243],"compartment,":[54],"locus":[56],"presumed":[58],"hyperactivity,":[60],"2.":[62],"evaluate":[64],"effects":[66],"prostacyclin":[68,322],"(PGI2),":[69],"a":[70,174,277],"most":[71,224],"potent":[72],"antiplatelet":[73,254],"agent":[74],"vasodilator.":[76],"A":[77],"total":[78],"59":[80],"patients":[81,88,249],"with":[82,91,232,250],"MI":[84,185,274],"were":[85,89,130],"studied.":[86,131],"22":[87],"instrumented":[90],"arterial":[92],"coronary":[94,288],"sinus":[95],"catheters":[96],"received":[98],"intravenous":[99],"infusion":[100],"PGI2,":[102,167,199],"13":[103],"+/-":[104,108],"4.5":[105],"ng/kg/min":[106],"(mean":[107],"SD),":[109],"for":[110,332],"90":[111],"minutes.":[112],"In":[113,261],"15":[114,248],"these":[116],"patients,":[117],"who":[118],"had":[119],"anterior":[121,251],"MI,":[122],"transcardiac":[123],"function":[125,314],"response":[127,191,215],"PGI2":[129,217,257],"results":[133],"are":[134,153,188,218,301],"as":[135],"follows:":[136],"Plasma":[137],"levels":[138],"beta-thromboglobulin":[140],"(beta-TG)":[141],"thromboxane":[144,238],"B2":[145],"(TxB2),":[146],"vivo":[148,202],"measures":[149],"activity,":[152],"elevated":[154],"three":[155],"ten":[157,246],"fold.":[158],"6-keto-prostaglandin":[159],"F1":[160],"alpha,":[161],"stable":[163],"end":[164],"product":[165],"less":[169],"than":[170,323],"10":[171],"pg/ml,":[172],"reflecting":[173],"leftward":[175],"shift":[176],"TxB2/PGI2":[179],"ratio.":[180],"Platelets,":[181],"circulating":[182],"(\"ischemic":[186],"platelets\")":[187],"hyperaggregable":[189],"adenosine":[193,210],"diphosphate":[194],"relatively":[196],"resistent":[197],"both":[200,283],"vitro.":[205],"Concentrations":[206],"cyclic":[209],"monophosphate":[211],"cAMP":[214],"diminished.":[219,260],"hyper-reactivity":[222,337],"intense":[225],"early":[226],"infarct":[228,304],"evolution":[229],"decreases":[231],"time.":[233],"Transcardiac":[234],"measurements":[235],"indicate":[236],"produced":[240],"compartment":[244],"MI.":[252],"effect":[255],"greatly":[259],"summary,":[262],"data":[264,300,327],"define":[265],"abnormal":[267],"pattern":[268],"behavior":[271],"characterized":[275],"by":[276],"pro-aggregatory":[278],"environment,":[279],"heightened":[280],"re-activity,":[282],"circulation,":[289],"relative":[291],"resistance":[292],"PGI2.":[294],"clinical":[296],"consequence":[297],"patient":[305],"phase":[309],"may":[310],"benefit":[311],"from":[312],"suppression":[315],"requires":[317],"significantly":[318],"greater":[319],"doses":[320],"normal":[324],"subjects.":[325],"also":[328],"suggest":[329],"future":[330],"directions":[331],"therapeutic":[333],"manipulation":[334],"setting":[340],"ischemia.":[344]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}